Human papillomavirus and associated cancers: Epidemiological aspects;Papillomavirus humains (HPV) et cancers associés: Aspects épidémiologiques

Revue Francophone des Laboratoires

Volumn 38, Issue 405, 2008, Pages 27-34

  Louie, Karly ^a,b   Didelot, Marie Noelle ^c   Damay, Audray ^c   Nagot, Nicolas ^c   Mayaud, Philippe ^b   Segondy, Michel ^c  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer; Epidemiology; HPV; Papillomaviruses

Indexed keywords

EID: 55049139027     PISSN: 1773035X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-035x(08)74275-8     Document Type: Review

References (53)

1. Ahdieh L., Munoz A., Vlahov D., Trimble C.L., Timpson L.A., Shah K., Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women, Am. J. Epidemiol. 151 (2000) 1148-57.
2. Ahdieh-Grant L., Li R., Levine A.M., Steward-Massad L., Strickler H.D., Minkoff H., Moxley M., Palefsky J., Sacks H., Burk R.D., Gange S.J., Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women, J. Natl.Cancer Inst. 96 (2004) 1070-76.
3. Asgari L.M., Kiviat N.B., Critchlow C.W., Stern J.E., Argenyi Z.B., Raugi G.J., Berg D., Odland P.B., Hawes S.E., de Villiers E.M., Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals, J. Invest. Dermatol. (2008, advance on line publication, Jan 10).
4. Castellsagué X., Bosch F.X., Muñoz N., Meijer C.J., Shah K.V., de Sanjose S., Eluf-Neto J., Ngelangel C.A., Chichareon S., Smith J.S., Herrero R., Moreno V., Franceschi S., Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners, N. Engl. J. Med. 346 (2002) 1105-12.
5. Castellsagué X., de Sanjosé S., Aguado T., Louie K.S., Bruni L., Muñoz J., Diaz M., Irwin K., Gacic M., Beuavais O., Albero G., Ferrer E., Byrne S., Bosch F.X., HPV and cervical cancer in the world, 2007 Report. WHO/ICO Information Centre on HPV and cervical cancer (HPV Information Centre).
6. Center for diseases and control. 1993, Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, Morb. Mortal. Wkly Rep. 41 (199X) 21-19.
7. Clifford G.M., Goncalves M.A., Franceschi S., Human papillomavirus types among women infected with HIV: a meta-analysis, AIDS 20 (2006) 2337-44.
8. Clifford G.M., Polesel J., Rickenbach M., Dal Maso L., Keiser O., Kofler A., Rapiti E., Levi F., Jundt G., Fisch T., Bordoni A., De Weck D., Franceschi S., Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy, J. Natl. Cancer Inst. 97 (2005) 425-32.
9. Daling J.R., Weiss N.S., Hislop T.G., Maden C., Coates R.J., Sherman K.J., Ashley R.L., Beagrie M., Ryan J.A., Corey L., Sexual practices, sexually transmitted diseases, and the incidence of anal cancer, N. Engl. J. Med. 317 (1987) 973-7.
10. de San José S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., Bosch F.X., Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, Lancet Infect. Dis. 7 (2007) 453-9.
11. de Vuyst H., Gichangi P., Estambale, B., Njuguna, E., Franceschi, S., Temmerman M., Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya, Int. J. Cancer 121 (2008) 244-6.
12. Didelot-Rousseau M.N., Nagot N., Costes-Martineau V., Vallès X., Ouedraogo A., Konate I., Weiss H.A., Van de Perre P., Mayaud P., Segondy M.M., Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso, Br. J. Cancer 95 (2006) 355-62.
13. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., Forastiere A., Gillison M.L., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, J. Natl. Cancer Inst. 100 (2008) 261-9
14. Ferlay J., Bray F., Pisani P., Parkin D.M., GLOBOCAN 2002 Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. IARC Press, Lyon 2004.
15. Forslund O., Iftner T., Andersson K., Lindelof B., Hradil E., Nordin P., Stenquist B., Kirnbauer R., Dillner J., de Villiers E.M., Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma, J. Infect. Dis. 196 (2007) 876-83.
16. Frisch M., Biggar R.J., Goedert J.J., Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome, J. Natl. Cancer Inst. 92 (2000) 1500-10.
17. Future II study group, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesion, N. Engl. J. Med. 356 (2007) 1915-27.
18. Handley J., Dinsmore W., Maw R., Corbett R., Burrows D., Bharucha H., Swann A., Bingham A., Anogenital warts in prepubertal children; sexual abuse or not? Int. J. STD AIDS 4 (1993) 271-9.
19. Handley J., Hanks E., Armstrong K., Bingham A., Dinsmore W., Swann A., Evans M.F., McGee J.O., O'Leary J., Common association of HPV2 with anogenital warts in prebubertal children, Pediatr. Dermatol. 14 (1997) 339-43.
20. Harwood C.A., Surentheran T., Sasieni P., Proby C.M., Bordea C., Leigh I.M., Wojnarowska F., Breuer J., McGregor J.M., Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin, Br. J. Dermatol. 150 (2004) 949-57.
21. Hawes S.E, Critchlow C.W, Sow P.S, Touré P., N'Doye I, Diop A., Kuypers J.M., Kasse A.A., Kiviat N.B., Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2, J. Natl. Cancer Inst. 98 (2006) 100-9.
22. Heard I., Schmitz V., Costagliola D., Orth G., Kazatchkine M.D., Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy, AIDS 12 (1998) 1459-64.
23. Hessol N.A., Seaberg E.C., Preston-Martin S., Massad L.S., Sacks H.S., Silver S., Melnick S., Abulafia O., Levine A.M., Cancer risk among participants in the women's interagency HIV study, J. Acquir. Immune Defic. Syndr. 36 (2004) 978-85.
24. Hobbs C.G., Sterne J.A., Bailey M., Heyderman R.S., Birchall M.A., Thomas S.J., Human papillomavirus and head and neck cancer: a systematic review and meta-analysis, Clin. Otolaryngol. 31 (2006) 259-66.
25. IARC. Monographs on the evaluation of carcinogenic risks to humans, vol. 90: human papillomaviruses. Lyon: International Agency for Research on Cancer, 2007.
26. International Collaboration on HIV and cancer, Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults, J. Natl. Cancer Inst. 92 (2000) 1823-3180.
27. Jamieson D.J., Duerr A., Burk R., Klein R.S., Paramsothy P., Shuman P., Cu-Uvin S., Shah K., Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection, Am. J. Obstet. Gynecol. 186 (2002) 21-7.
28. Krane J.F., Granter S.R., Trask C.E., Hogan C.L., Lee K.R., Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases, Cancer 93 (2001) 8-15.
29. Lacey C.J., Lowndes C.M., Shah K., Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV 6/11 disease, Vaccine Suppl.3 (2006) S35-41.
30. Lillo F.B., Ferrari D., Veglia F., Origoni M., Grasso M.A., Lodini S., Mastrorilli E., Taccagni G., Lazzarin A., Uberti-Foppa C., Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy, J. Infect. Dis. 184 (2001) 547-51.
31. Massad L.S., Silverberg M.J., Springer G., Minkoff H., Hessol N., Palefsky J.M., Strickler H.P., Levine A.M., Sacks H.S., Moxley M., Heather Watts D., Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with human immunodeficiency virus, Am. J. Obstet. Gynecol. 190 (2004) 1241-48.
32. Mitchell H., Medley G., Gordon I., Giles G., Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit, Br. J. Cancer 71 (1995) 894-7.
33. Moore A.L., Sabin C.A., Madge S., Mocroft A., Reid W., Johnson M.A., Highly active antiretroviral therapy and cervical intraepithelial neoplasia, AIDS 16 (2002) 927-9.
34. Munoz N., Castellsague X., Berrington de Gonzalez A., Gissman L., Chapter 1. HPV in the etiology of human cancer, Vaccine 24 Suppl.3 (2006) S1-S10.
35. Obalek S., Misiewicz J., Jablonska S., Favre M., Orth G., Childhood condyloma acuminatum: association with genital and cutaneous papillomaviruses, Pediatr. Dermatol. 10 (1993) 101-6.
36. Orlando G., Fasolo M.M., Schiavini M., Signori R., Cargnel A., Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients, AIDS 13 (1999) 424-5.
37. Parkin D.M., Bray F., Chapter 2: The burden of HPV-related cancers, Vaccine 24 Suppl.3 (2006) S3-S25.
38. Partridge J.M., Hughes J.P., Feng Q., Winer R.L., Weaver B.A., Xi L.F., Stern M.E., Lee S.K., O'Reilly S.F., Hawes S.E., Kiviat N.B., Koutsky L.A., Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students, J. Infect. Dis. 196 (2007) 1128-36.
39. Piketty C., Darragh T.M., Da Costa M., Bruneval P., Heard I., Kazatchkine M.D., Palefsky J.M., High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse, Ann. Intern. Med. 183 (2003) 453-9.
40. Pretet J.L., Jacquard A.C., Carcopino X., Charlot J.F., Bouhour D., Kantelip B., Soubeyrand B., Leomach Y., Mougin C., Riethmuller D., Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study, Int. J. Cancer 122 (2008) 428-32
41. Pretet J.L., Jacquard A.C., Carcopino X., Monnier-Benoit S., Averous G., Soubeyrand B., Leomach Y., Mougin C., Riethmuller D., Human papillomavirus genotype distribution in high grade cervical lesions (CIN2/3) in France: EDITH study, Int J. Cancer 122 (2008),424-7.
42. Raab SS., Can glandular lesions be diagnosed in pap smear cytology?, Diagn. Cytopathol. 23 (2000 127-33.
43. Rowhani-Rahbar A., Hawes S.E., Sow P.S., Toure P., Feng Q., Dem A., Dembele B., Critchlow C.W., N'Doye I., Kiviat N.B., The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women, J. Infect. Dis. 196 (2007) 887-94.
44. Sahasrabuddhe V.V., Mwanahamuntu M.H., Vermund S.H., Huh W.K., Lyon M.D., Stringer J.S., Parham G.P., Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia, Br. J. Cancer 96 (2007) 1480-3.
45. Schuman P., Ohmit S.E., Klein R.S., Duerr A., Cu-Uvin S., Jamieson D.J., Anderson J., Shah K.V., Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women, J. Infect. Dis. 188 (2003) 128-36.
46. Smith J.F., Brownlow M., Brown M., Kowalski R., Esser M.T., Ruiz W., Barr E., Brown D.R., Bryan J.T., Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions, Human Vaccines 3 (2007) 109-16.
47. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford G.M., Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update, Int. J. Cancer 121 (2007) 621-32.
48. Sterling J.C., Human papillomaviruses and skin cancer, J. Clin. Virol. 32 Suppl.1 (2005) S67-S71.
49. Strickler H.D., Palefsky J.M., Shah K.V., Anastos K., Klein R.S., Minkoff H., Duerr A., Massad L.S., Celentano D.D., Hall C., Fazzari M., Cu-Uvin S., Bacon M., Schuman P., Levine A.M., Durante A.J., Gange S., Melnick S., Burk R.D., Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women, J. Natl. Cancer Inst. 95 (2003) 1062-71.
50. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright T.C.,. Human papillomavirus infection in women infected with the human immunodeficiency virus, N. Engl..J..Med. 337 (1997) 1343-49.
51. Winer R.L., Feng Q., Hughes J.P., O'Reilly S.O., Kiviat N.B., Koutsky L.A., Risk of female human papillomavirus acquisition associated with first male sex partner, J. Infect. Dis. 197 (2008) 279-82.
52. Winer R.L., Hughes J.P., Feng Q., O'Reilly S., Kiviat N.B., Holmes K.K., Koutsky L.A., Condom use and the risk of genital human papillomavirus infection in young women, N. Engl. J. Med. 354 (2006) 2645-54.
53. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., Koutsky L.A., Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students, Am. J. Epidemiol. 157 (2003) 218-26.